Business
EU’s drug regulator backs AstraZeneca vaccine after safety investigation – Sydney Morning Herald
The regulator said the vaccine did not increase the overall risk of blood clots but cannot rule out a link with two very rare blood disorders.
This pandemic is costing lives. We have vaccines that are safe and effective and can prevent deaths and hospitalisations. We need to use those vaccines.
The countries had been under pressure to urgently restart the AstraZeneca rollout following the EMAs conclusions.
Working with data from other agencies around the world, the EMA found the number of thromboembolic events reported during trials and the broader rollout was 469 lower than what would normally be expected in the general population.
Sabine…
-
Business13 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
General9 hours agoFormer truck driver’s garage memorabilia collection sold to Westonia to drive tourism
-
Noosa News15 hours agoInside the big change in homebuyer habits during the Christmas holidays
-
Noosa News9 hours agoJetstar flights resume across Australia after Airbus A320 software issue identified